Evolution of the Average Target: Bastide Le Confort Médical

Evolution of the Average Target - Bastide Le Confort Médical

Evolution of the Target Price: Bastide Le Confort Médical

Evolution of the Target Price - Bastide Le Confort Médical

Changes in Analyst Recommendations: Bastide Le Confort Médical

93.YULqHXU0LPAwte3mZ5AlkWnla6TMvm1DQbkSlhB3HzQ.MHWEVkd_XKlC-L-yD6Zd4wTIDNau_TkXcYtdpEIgcXM1KoB3KngUxUKDgg~99c9983b3b21507af07d864ad4ab44ed
09-28 AlphaValue/Baader Europe Upgrades Bastide Le Confort Médical to Buy MT
09-04 Bastide Le Confort Medical: FY sales beat guidance - end of coverage on 1st of October Alphavalue
05-18 Baader Europe maintains stance on Bastide le Confort Médical Zonebourse
05-15 Bastide Le Confort Medical: Guidance confirmed despite transitory regulatory headwinds in Q3 Alphavalue
03-19 Bastide Le Confort Medical: Sound H1 results, solid deleveraging, and reaffirmed FY guidance Alphavalue
03-19 Bastide results in line with guidance, says Oddo BHF Zonebourse
12-05 Bastide Le Confort Medical cuts EPS guidance Alphavalue
25-10-27 Bastide Le Confort Medical: In-line FY24/25 underlying results; smooth deleveraging Alphavalue
25-09-05 Bastide Le Confort Medical: In-line FY24/25 revenue; reconfirmed guidance Alphavalue
25-07-04 Bastide Le Confort Medical: Impact of strategic divestitures effective from next FY Alphavalue
25-06-06 Bastide: Oddo BHF still a buyer Zonebourse
25-05-16 Bastide Le Confort Medical: Reconfirmed guidance backed by compelling 9M turnover Alphavalue
25-03-20 Bastide Le Confort Medical: EPS cut (2024: -52.7%, 2025: -37.4%) Alphavalue
25-03-20 Bastide Le Confort Medical: Profitability gains neutralized by heavier financial expenses Alphavalue
25-03-20 Bastide: price target raised by Oddo BHF Zonebourse
25-03-14 Bastide Le Confort Medical: Debt reduction on the right trajectory Alphavalue
25-02-14 Bastide Le Confort Medical: Crystallizing a better revenue mix Alphavalue
24-11-27 Bastide: up sharply, a broker raises his recommendation Zonebourse
24-11-27 Bastide: Oddo BHF upgrades to 'outperform', raises target Zonebourse
24-11-15 Bastide Le Confort Medical: Better revenue mix; progress in portfolio review Alphavalue
24-10-28 Bastide Le Confort Medical: Margin build-up and debt reduction on a good trajectory Alphavalue
24-08-30 Bastide Le Confort Medical: Stronger qoq organic growth; guidance reiterated Alphavalue
24-05-15 Bastide Le Confort Medical: De facto maintained guidance; more disposals to propel debt reduction Alphavalue
24-04-09 Bastide Le Confort Medical: EPS upgrade (2023: 0.0%, 2024: +1.6%) Alphavalue
24-03-21 Bastide Le Confort Medical: The prioritised debt reduction awaits further visible progress Alphavalue

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - +47.62%
+34.35%
+1.81%
-4.26%
+31.24%
+7.72%
+10.56%
+17.33%
+8.17%
+6.74%
Average +16.13%
Weighted average by Cap. +14.05%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
19.48EUR
Average target price
31.00EUR
Spread / Average Target
+59.14%
High Price Target
31.00EUR
Spread / Highest target
+59.14%
Low Price Target
31.00EUR
Spread / Lowest Target
+59.14%

Analyst Consensus Detail

Analyst consensus - Bastide Le Confort Médical

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Bastide Le Confort Médical
Trader
-
Investor
Global
-
Quality
ESG MSCI
-
Ratings Surperformance© - Bastide Le Confort Médical
  1. Stock Market
  2. Stocks
  3. BLC Stock
  4. Consensus Bastide Le Confort Médical